Editorial
doi: 10.1200/JCO.2005.10.951.
Epub 2005 Jan 27.
Epidermal growth factor receptor inhibitors in colorectal cancer: it's time to get back on target
- PMID: 15677698
- DOI: 10.1200/JCO.2005.10.951
Item in Clipboard
Editorial
Epidermal growth factor receptor inhibitors in colorectal cancer: it's time to get back on target
J Clin Oncol.
.
No abstract available
Comment on
-
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.J Clin Oncol. 2005 Mar 20;23(9):1803-10. doi: 10.1200/JCO.2005.08.037. Epub 2005 Jan 27. J Clin Oncol. 2005. PMID: 15677699
Similar articles
-
A case of ecthyma during therapy with an epidermal growth factor receptor inhibitor.Eur J Dermatol. 2014 Jul-Aug;24(4):511-2. doi: 10.1684/ejd.2014.2390. Eur J Dermatol. 2014. PMID: 25266748 No abstract available.
-
Targeting the epidermal growth factor receptor in colorectal carcinoma.Cancer Nurs. 2007 Jul-Aug;30(4 Suppl 1):S1-9. doi: 10.1097/01.NCC.0000281757.78081.74. Cancer Nurs. 2007. PMID: 17666985 Review.
-
Papulo-pustular eruption during cetuximab treatment.G Ital Dermatol Venereol. 2008 Feb;143(1):87-8. G Ital Dermatol Venereol. 2008. PMID: 18833056 No abstract available.
-
Anti-EGFR monoclonal antibodies for treatment of colorectal cancers: development of cetuximab and panitumumab.J Clin Pharmacol. 2012 Feb;52(2):128-55. doi: 10.1177/0091270010395940. J Clin Pharmacol. 2012. PMID: 21427284 Review.
-
[Molecular targets in colon cancer].Ther Umsch. 2006 Apr;63(4):243-8. doi: 10.1024/0040-5930.63.4.243. Ther Umsch. 2006. PMID: 16689454 Review. German.
Cited by
-
HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with RAS Wild Type Metastatic Colorectal Cancer.Cancers (Basel). 2021 Feb 5;13(4):638. doi: 10.3390/cancers13040638. Cancers (Basel). 2021. PMID: 33562755 Free PMC article.
-
Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients.Onco Targets Ther. 2009 Feb 18;2:17-27. Onco Targets Ther. 2009. PMID: 20616891 Free PMC article.
-
Circulating tumour cells as a predictive factor for response to systemic chemotherapy in patients with advanced colorectal cancer.Mol Oncol. 2008 Dec;2(4):349-55. doi: 10.1016/j.molonc.2008.09.001. Epub 2008 Sep 16. Mol Oncol. 2008. PMID: 19383356 Free PMC article.
-
Metastatic colorectal cancer: current systemic treatment options.Drugs. 2007;67(13):1851-67. doi: 10.2165/00003495-200767130-00004. Drugs. 2007. PMID: 17722954 Review.
-
Protocol modifications influence the result of EGF receptor immunodetection by EGFR pharmDx in paraffin-embedded cancer tissues.Pathol Oncol Res. 2006;12(4):243-6. doi: 10.1007/BF02893421. Epub 2006 Dec 25. Pathol Oncol Res. 2006. PMID: 17189989
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
